Company Filing History:
Years Active: 2022
Title: Innovations by Chi Ee Peter See
Introduction
Chi Ee Peter See is a notable inventor based in Singapore, recognized for his contributions to the field of immunology. He has developed innovative methods that enhance the understanding and treatment of diseases through the identification of specific cell types.
Latest Patents
Chi Ee Peter See holds a patent titled "Methods for the identification, targeting and isolation of human dendritic cell (DC) precursors 'pre-DC' and their uses thereof." This patent outlines biomarkers for detecting and identifying precursors of conventional dendritic cells (cDC), specifically pre-DCs and their subsets. The biomarkers include CD169, CD327, AXL, CD271, CD324, and their combinations. The patent also describes methods for diagnosing diseases by determining the number of pre-DC cells in a sample compared to a control. Furthermore, it includes treatment methods involving the administration of antibodies against the identified biomarkers. An immunogenic composition that elicits an immune response against infectious diseases or cancer is also disclosed in this patent. Chi Ee Peter See has 1 patent to his name.
Career Highlights
Chi Ee Peter See is affiliated with the Agency for Science, Technology and Research, where he applies his expertise in immunology to advance scientific research and innovation. His work has significant implications for understanding immune responses and developing therapeutic strategies.
Collaborations
Chi Ee Peter See collaborates with Florent Ginhoux, a fellow researcher in the field, to further explore the potential applications of their findings in immunology.
Conclusion
Chi Ee Peter See's innovative work in identifying and utilizing dendritic cell precursors represents a significant advancement in immunological research. His contributions have the potential to improve disease detection and treatment strategies, showcasing the importance of innovation in science.